Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

[Involvement of chronic inflammation in chronic diseases and diabetic complications].

Manabe I.

Nihon Rinsho. 2012 Jul;70 Suppl 5:248-52. Japanese. No abstract available.

PMID:
23156402
2.

Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.

Lee YH, Pratley RE.

J Cardiopulm Rehabil Prev. 2007 Jan-Feb;27(1):2-10. Review. No abstract available.

PMID:
17474638
3.

Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients.

Kato A, Ishida J, Endo Y, Takita T, Furuhashi M, Maruyama Y, Odamaki M.

Nephrol Dial Transplant. 2011 Jun;26(6):1967-76. doi: 10.1093/ndt/gfq652. Epub 2010 Oct 27.

PMID:
20980356
4.

Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.

Wang MC, Tsai WC, Chen JY, Huang JJ.

Am J Kidney Dis. 2005 Mar;45(3):494-501.

PMID:
15754271
5.

[Obesity and chronic kidney disease].

Parlongo G, Zoccali C.

Recenti Prog Med. 2010 Feb;101(2):57-60. Review. Italian.

PMID:
20433001
6.

Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients.

Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L, Cignarelli M.

Nephrol Dial Transplant. 2011 Mar;26(3):892-8. doi: 10.1093/ndt/gfq522. Epub 2010 Aug 26.

PMID:
20798120
7.

[Inflammation and vascular calcifications].

Six I, Massy ZA.

Nephrol Ther. 2010 Feb;6 Suppl 1:S13-8. doi: 10.1016/S1769-7255(10)70006-7. French.

PMID:
20172495
8.

The evolving role of inflammation in obesity and the metabolic syndrome.

Lee YH, Pratley RE.

Curr Diab Rep. 2005 Feb;5(1):70-5. Review.

PMID:
15663921
9.

Adiponectin: a key player in obesity related disorders.

Matsuzawa Y.

Curr Pharm Des. 2010 Jun;16(17):1896-901. Review.

PMID:
20370675
10.

The emerging biology of adipose tissue in chronic kidney disease: from fat to facts.

Axelsson J.

Nephrol Dial Transplant. 2008 Oct;23(10):3041-6. doi: 10.1093/ndt/gfn376. Epub 2008 Jul 16. Review. No abstract available.

PMID:
18632589
11.

Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.

Kim W, Hudson BI, Moser B, Guo J, Rong LL, Lu Y, Qu W, Lalla E, Lerner S, Chen Y, Yan SS, D'Agati V, Naka Y, Ramasamy R, Herold K, Yan SF, Schmidt AM.

Ann N Y Acad Sci. 2005 Jun;1043:553-61. Review.

PMID:
16037278
12.

Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis.

Theuma P, Fonseca VA.

Curr Diab Rep. 2003 Jun;3(3):248-54. Review.

PMID:
12762974
13.

Haemodialysis, atherosclerosis and inflammation-identifying molecular mechanisms of chronic vascular disease in ESDR patients.

Walter R, Mischak H, Haller H.

Nephrol Dial Transplant. 2002;17 Suppl 3:24-9. Review. No abstract available.

PMID:
11912296
14.

Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation.

Welsh RC, Cockfield SM, Campbell P, Hervas-Malo M, Gyenes G, Dzavik V.

Transplantation. 2011 Jan 27;91(2):213-8. doi: 10.1097/TP.0b013e3181ff4f61.

PMID:
21048531
15.

Diabetes and kidney disease.

Ulrich B.

Nephrol Nurs J. 2009 Sep-Oct;36(5):461. Review. No abstract available.

PMID:
19856806
16.

Atherothrombosis, inflammation, and diabetes.

Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM.

J Am Coll Cardiol. 2003 Apr 2;41(7):1071-7. Review.

17.

Role of the gut in visceral fat inflammation and metabolic disorders.

Lam YY, Mitchell AJ, Holmes AJ, Denyer GS, Gummesson A, Caterson ID, Hunt NH, Storlien LH.

Obesity (Silver Spring). 2011 Nov;19(11):2113-20. doi: 10.1038/oby.2011.68. Epub 2011 Sep 1. Review. No abstract available.

18.

Obesity related kidney disease.

Mathew AV, Okada S, Sharma K.

Curr Diabetes Rev. 2011 Jan;7(1):41-9. Review.

PMID:
21067508
19.

Impact of concomitant diabetes and chronic kidney disease on preload-induced changes in left ventricular diastolic filling in hypertensive patients.

Iwashima Y, Horio T, Suzuki Y, Takagi T, Kamide K, Ohishi M, Ogihara T, Yoshikawa J, Kawano Y, Rakugi H.

J Hypertens. 2011 Jan;29(1):144-53. doi: 10.1097/HJH.0b013e32833f387c.

PMID:
20881868
20.

Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease.

Yoon SH, Choi NW, Yun SR.

Nephron Clin Pract. 2009;111(1):c1-6. doi: 10.1159/000175444. Epub 2008 Nov 20.

PMID:
19023220

Supplemental Content

Support Center